SciSparc Says Majority-Owned Subsidiary NeuroThera Achieved End-To-End Hybrid Quantum-Classical Workflow Milestone For Clinical Trial Data Analytics Platform, Executed In Simulation Environment

Loading news article.

SciSparc Says Majority-Owned Subsidiary NeuroThera Achieved End-To-End Hybrid Quantum-Classical Workflow Milestone For Clinical Trial Data Analytics Platform, Executed In Simulation Environment | WAPE

SciSparc Says Majority-Owned Subsidiary NeuroThera Achieved End-To-End Hybrid Quantum-Classical Workflow Milestone For Clinical Trial Data Analytics Platform, Executed In Simulation Environment

Article summary

Related companies

Comments —